Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre.

Carol L Shields Zeynep BasSameeksha TadepalliLauren A DalvinRaksha RaoRachel SchwendemanSara E LallyJerry A ShieldsAmish ShahAnn Leahey

Published in: The British journal of ophthalmology (2020)

Frontline IVC (plus additional IAC and/or plaque radiotherapy) for retinoblastoma provided complete tumour control for groups A (96%), B (91%), C (91%), D (71%) and E (32%), avoiding enucleation or EBRT and was lasting for up to 20 years.

Keyphrases

locally advanced
early stage
optical coherence tomography
inferior vena cava
radiation therapy
rectal cancer
coronary artery disease
high dose
squamous cell carcinoma
radiation induced
type diabetes
adipose tissue
metabolic syndrome
chemotherapy induced
skeletal muscle